Serves as a mentor and advisor to private and public boards and CEOs, concentrating on strategic business direction, innovation, turnarounds and board governance. Works with emerging company CEOs and corporate teams to help them raise capital, reach their highest levels of achievement, uncover sensitive issues and generate superior options for action and foster innovation. Using 40+ years of successful problem solving and leadership to bring clarity and help focus teams on facing and conquering the tough challenges, including appropriately defining themselves, gaining financing, and driving products to the market and building an innovation culture.Currently working with :Molecular Assemblies - Chairman (Since 2014) ParaNetics - Chairman (Since 2014)EdgeOne Medical (Since 2015)SynBioBeta - John Cumbers (Since 2020)Western States Fire, Chairman (Since 2022)

The leading trade organization for the life sciences industry in California. I am on the executive committee of the board and led the organization's political policy committee and serve as board lead on the strategic planning committee. During the time on the Board, the organization has grown from under 200 members to over 1,600 members, established a extraordinary purchasing group with over $1 billion in services, a leading lobbyist organization in Sacramento and Washington DC and a group health provider trust serving small companies with great health coverage.

Larry Stambaugh was the Managing Director at the Centre for Bioinspiration for the San Diego Zoo Global. He joined the Zoo to establish the Centre that will develop the genius of nearly 4 billion years of adaptations in animals and plants into innovative products and services. The Centre is also developing an incubator model that can be connected around the world to bring together private, public and academic organizations to effectively develop nature’s intelligence for the sustainable advancement of mankind, animals, aquatic life and plants. Innovations from the Centre are expected to span the full spectrum of uses by mankind including sustainable materials, life science therapeutics, diagnostics and medical devices, energy, architecture, mathematical algorithms, organizational development, high technology, and many others.

As a mentor to emerging companies, work with other seasoned executives to help young companies move toward funding, marketing and advancing their young companies their technologies.

Turn Around of a Supply Chain Company.In early 2009 I was recruited by the Cryoport Board to turn-around a public Company that had seven weeks of cash, no sales, wrong business model, inept leadership & Board and large aggressive debt holders plus upset shareholders. Public markets were inaccessible at that time due to the subprime housing market crisis. I took on the CEO job stating that I was skeptical that the Company could be saved in these impossible circumstances.A brief summary of the key elements of the turn-around are highlighted in the following list. In short, the turn-around was highly successful and resulted in a Company that, instead of bankruptcy, grew over the next ten years to a Company with a $3.7 billion market capitalization.-Established trust in the team that management will tell them the truth.-Secured interim funding, to keep the Company viable, through an upper mid-west investment banking firm that had a large stake in the Company.-Negotiated with the highly aggressive debt firm to have them give up several convents and to support the interim funding.-Changed the business model from being a “manufacturer of supply chain containers sold to customers” to a supplier of shipping services to deliver turn key shipping and tracking of the containers for ease of use - customers embraced the new model.- Develop the infrastructure to deliver the end-to-end supply chain solution.-Established a strategic relationship directly with Fred Smith, CEO at Federal Express to be a key partner in the supply chain solution.-Engaged key customers and established proof of principle model.-Raise more than $12 million of capital to support the development and market launch under the new business model.-During this period brought on key management personnel including a strong CFO, an IT expert to set the new tracking model, and sales professionals.-Rebrand the Company and established the new business model for industry leadership.

A non profit organization that provides education and peer networking to Board of Director members. As Chairman, grew the organization to the largest regional group of directors in the U.S. Awarded "Director of the Year" recognition an unprecedented three times for my leadership and educational contribution. Founded, and led for 12 years, a highly lauded and unique national corporate governance conference that attracted the world's top Board members, public shareholders, academics and regulators where the debated with each on panels about the hottest corporate governance topics. The first year of the conference it was dubbed by a top corporate governance leader as "the Woodstock of Corporate Governance" due to its unique format of presenting both sides of a point of view on hot topics.

A co-founder of Ridge Diagnostics, a company that is commercializing a first ever blood test for Major Depressive Disorder. This is a significant breakthrough - there has never been a blood test for any neurological disease. It is believed that this may significantly enhance and advance the treatment and management for patients with depression.

A company commercializing an innovative carrier for mRNA technology in multiple indications. this was a short term turnaround assignment. the Company elected to not go public ending the assigment.

Raised over $350 million including private equity, IPO in the U.S and follow-on secondary and PIPE transactions. Listed company on public markets in Europe while growing market capitalization from $15 million to $1.5 billion.Prepared initial business plan, assembled highly experienced management team and acquired technologies in cancer and liver disease.Conducted 17 clinical trials in 20 countries on three continents which led to the approval of a novel leukemia therapy, and presented complex science to and negotiated strategic partnerships with Fortune 100 pharmaceutical companies.Divested of diagnostic division and acquired exclusive worldwide rights to apoptosis technologies through the acquisition of a biotechnology company. Identified and completed a strategic transaction to merge Maxim with a New Jersey biotech company after the Company had negative clinical trial results and FDA delays. Drug was approved by EU for treatment of the most common adult leukemia.

Recruited to restructure an international environmental services and instrument manufacturing company with growing pains and significant customer service issues. The top priorities were to take advantage of a growing market, provide capital for expansion, and assemble a management team and leading scientists to serve Fortune 500 customers.• Doubled sales from $9.7 million to $21 million, achieved record earnings, and returned over 20% on beginning equity.• Attracted and hired over 200 new associates, including renowned world leaders in environmental science and many advanced degree scientists.• Instituted intensive training program to develop management skills, communication abilities, integration of new associates into Company, and focus on quality concepts.• Directed company’s offshore expansion, resulting in over 25% of sales from Europe and Pacific Rim.

Led the roll up of a large midwestern bank into a public multi-bank holding company. Increased banking revenues and profits from break even to over $3 million in first year. Led the acquisition and integration team for adding banks. Positioned the company to be acquired by a large regional bank holding company.

Built a retail General Motors dealership into a multi company organization including other dealerships, an insurance company, a finance company and warranty company. Became one of the top profitability dealers in the U.S. Implemented a hedging strategy during high interest periods that was studied and copied by General Motors for other companies.

Engaged in the audit practice at the accounting firm. Participated in high profile consulting projects for the Federal Reserve System, The AICPA in inter firm auditing and the first computer auditing by an accounting firm.